As the coronavirus outbreak shows, viruses are a constant threat to humanity. Vaccines are regularly developed and deployed against specific viruses, but that process takes a lot of time, doesn’t help everyone who needs protection, and still leaves people exposed to new outbreaks and new viruses.
Now, researchers at Massachusetts General Hospital (MGH) have uncovered a novel potential antiviral drug target that could lead to treatments protecting against a host of infectious diseases – creating a pan, or universal, treatment. Their work suggests that the protein Argonaute 4 (AGO4) is an “Achilles heel” for viruses.
AGO4 is one of a family of AGO proteins. Until now, there has been little evidence of whether they have individual roles. The researchers, led by Kate L. Jeffrey, PhD, and her collaborators found that AGO4 plays a key role protecting cells against viral infections.
Specifically, this protein is uniquely antiviral in mammalian immune cells. The group studied the anti-viral effects of several Argonaute proteins, and found that only cells that were deficient in AGO4 were “hyper-susceptible” to viral infection. In other words, low levels of AGO4 make mammalian cells more likely to become infected.
This study was published today by Cell Reports.
The MGH researchers suggest that boosting levels of AGO4 could shore up the immune system to protect against multiple viruses. “The goal is to understand how our immune system works so we can create treatments that work against a range of viruses, rather than just vaccines against a particular one,” says Jeffrey.
Mammals have four Argonaute proteins (1-4), which act by silencing genes and which are remarkably conserved throughout multiple living things, including plants. These are RNA interference (RNAi) and microRNA effector proteins and RNAi is the major antiviral defense strategy in plants and invertebrates. Studies of influenza infected mice have shown that AGO4-deficient animals have significantly higher levels of the virus.
The next steps are to “determine how broad spectrum this is to any virus type,” says Jeffrey. “Then we need to discover how to boost AGO4 to ramp up protection against viral infections.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Universal antiviral drug target
- Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
RA Capital Management with significant participation by Bain Capital Life Sciences as well as BVF Partners and Canaan Partners to fund Phase 2b clinical trial SAN DIEGO, CA, USA I April 24, 2024 I ...
- Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses
The new strategy would eliminate the need to create annual vaccines for viruses such as influenza, or SARS-CoV-2, because it targets a part ... This could be the universal vaccine that we have ...
- WHO: Hepatitis viruses kill 3,500 people a day
There are effective and cheap generic drugs ... hep B received antiviral treatment by the end of 2022, the report said. For hep C, just 20 percent -- or 12.5 million people -- had been treated. "These ...
- Hepatitis viruses kill 3,500 people daily: WHO
There are effective and cheap generic drugs which can treat these viruses. Yet only three per cent of those with chronic hep B received antiviral ... below the global targets to treat 80 per ...
- Revealing global barriers to curative hep C treatment access
"Current direct acting antiviral treatments cure hepatitis C ... who led the research at the Kirby Institute. "Universal access to health coverage means all people should have access to the ...
Go deeper with Google Headlines on:
Universal antiviral drug target
[google_news title=”” keyword=”universal antiviral drug target” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Viruses
- Viruses Keep Mice from Stressing Out
“We always think of viruses as something we want to get rid of and are negative,” said John Cryan, a stress neurobiologist at the University College Cork and coauthor of the study. “What this paper ...
- Oncolytic Viruses: A Promising New Option in Cancer Treatment
As part of its Speaking Out video series, Targeted Oncology spoke with Howard D. Edington, MD, about the benefits of using oncolytic viruses in cancer treatment.
- U.S. Tightens Rules on Risky Virus Research
A long-awaited new policy broadens the type of regulated viruses, bacteria, fungi and toxins, including those that could threaten crops and livestock.
- A Fight About Viruses in the Air Is Finally Over. Now It’s Time for Healthy Venting
WHO now admits the COVID virus and other germs spread “through the air.” This plain language may help improve research and action to fight disease ...
- The wasps that tamed viruses
If you puncture the ovary of a wasp called Microplitis demolitor, viruses squirt out in vast quantities, shimmering like iridescent blue toothpaste. “It’s very beautiful, and just amazing that there’s ...
Go deeper with Google Headlines on:
Viruses
[google_news title=”” keyword=”viruses ” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]